The focus above is on research creating the perception of commerciality but there's no evidence of commerciality imo .
CBD solubility has already been established and commercialised with other compounds
Perhaps ave or Lambert needs to prove tpm superiority over and above the readily available lower cost alternatives if market interest is being sought .
The focus above is on research creating the perception of...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.338M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 44954072 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 46237350 | 29 |
View Market Depth
| Last trade - 11.42am 27/09/2024 (20 minute delay) ? |
| AVE (ASX) Chart |
Day chart unavailable